Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 2

2(28.6%)

Phase 1

1(14.3%)

Phase 4

1(14.3%)

7Total

N/A(3)

Phase 2(2)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05180994Phase 1Recruiting

Topical Infliximab in Eyes With Penetrating Keratoplasty

Role: collaborator

NCT05033301Not ApplicableRecruiting

Evaluating the Effectiveness of the Nurse Ned Clinic

Role: collaborator

NCT06323707Phase 2Recruiting

The IMPACT Implementation-Effectiveness Trial

Role: collaborator

NCT06792214Phase 4Recruiting

Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial

Role: collaborator

NCT03428373Phase 2Active Not Recruiting

Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma

Role: collaborator

NCT02777047Not ApplicableCompleted

Coordination of Oral Anticoagulant Care at Hospital Discharge

Role: collaborator

NCT04784858Unknown

Integrating a Parenting Intervention Into Substance Use Treatment: A Feasibility Study

Role: collaborator

NCT04508959Unknown

The McMaster Multi-Regional COVID-19 Hospital Case Registry

Role: collaborator

NCT02703805Not ApplicableCompleted

Fit For Function: A Community Wellness Program for Persons With Stroke

Role: collaborator

All 9 trials loaded